Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Mortality Factor 4 (MORF4) (Middle Region) Peptid

MORF4 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN980185
  • Target Alle MORF4 Produkte
    MORF4 (Mortality Factor 4 (MORF4))
    Protein Region
    Middle Region
    Spezies
    Human
    Quelle
    • 1
    Synthetic
    Applikation
    Blocking Peptide (BP), Western Blotting (WB)
    Produktmerkmale
    This is a synthetic peptide designed for use in combination with anti-MORF4 antibody (Catalog #: ARP47609_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Aufreinigung
    Purified
  • Applikationshinweise
    Each Investigator should determine their own optimal working dilution for specific applications.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Konzentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handhabung
    Avoid repeated freeze-thaw cycles.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    MORF4 (Mortality Factor 4 (MORF4))
    Synonyme
    CSR Peptide, CSRB Peptide, SEN Peptide, SEN1 Peptide, mortality factor 4 (pseudogene) Peptide, MORF4 Peptide
    Hintergrund
    Cellular senescence, the terminal nondividing state that normal cells enter following completion of their proliferative potential, is the dominant phenotype in hybrids of normal and immortal cells. Fusions of immortal human cell lines with each other have led to their assignment to 1 of several complementation groups. MORF4 is a gene on chromosome 4 that induces a senescent-like phenotype in cell lines assigned to complementation group B.Cellular senescence, the terminal nondividing state that normal cells enter following completion of their proliferative potential, is the dominant phenotype in hybrids of normal and immortal cells. Fusions of immortal human cell lines with each other have led to their assignment to 1 of several complementation groups. MORF4 is a gene on chromosome 4 that induces a senescent-like phenotype in cell lines assigned to complementation group B.[supplied by OMIM].

    Alias Symbols: CSR, CSRB, SEN, SEN1

    Protein Interaction Partner: SIN3A

    Protein Size: 235
    Molekulargewicht
    27 kDa
    Gen-ID
    10934
    NCBI Accession
    NM_006792, NP_006783
Sie sind hier:
Kundenservice